Sinopharm Group Co. Ltd. (SEHK: 1099)
Health Care · Health Care Providers & Services · CN
HK$14.87
+1.16% today · -20.5% 1Y
Sinopharm Group Co. Ltd. (SEHK: 1099) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $5.91B and employs 90,447 people.
Over the last twelve months the share price has lost 20.5%, trading between 14.55 and 22.34.
Tweenvest scores Sinopharm Group Co. Ltd. across four factors: quality 73/100, value 60/100, growth 11/100, dividend 48/100. Its strongest factor is quality.
1099 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.91B
- Revenue (TTM)
- $84.20B
- P/E
- 5.67
- EPS
- 2.27
- Dividend yield
- 5.49%
- Beta (5Y)
- 0.46
- 52-week high
- HK$22.34
- 52-week low
- HK$14.55
- Avg volume (3M)
- —
- Shares outstanding
- 3.12B
- Employees
- 90,447
- Next earnings
- —
About Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activities are organized across four main divisions. Its Pharmaceutical Distribution segment supplies pharmaceutical goods to a wide range of clients, including hospitals, fellow distributors, retail pharmacies, and clinics. This division additionally offers extensive distribution, logistics, and value-added support to both domestic and international manufacturers and suppliers in the pharmaceutical and healthcare sectors. The Medical Devices segment is solely focused on the distribution of various medical equipment. Through its Retail Pharmacy division, Sinopharm manages and franchises a vast chain of drug stores, with an impressive 10,259 locations as of December 31, 2021. The "Other Business" segment is involved in the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core areas, the company also engages in property rental and management. It further distributes specialized items such as medical instruments, traditional Chinese herbal medicines, antibiotics, and biological products. Sinopharm provides a comprehensive array of services, including IT development, medicine and health consultations, investment services, import/export facilitation for goods and technology, various business and market information consulting, and the organization of conventions and exhibitions. Moreover, it oversees medical project investments, offers related consulting, and provides technological training. Notably, Sinopharm Group has established a strategic alliance with I-Mab to enhance its commercial capabilities and accelerate its market entry strategies. Founded in Shanghai, China, in 2003, Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.
- ISIN
- CNE100000FN7
- Founded
- 2003
- Listed since
- Sep 23, 2009
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sonic Healthcare LimitedASX: SHL | $6.43B | AU$18.65 | -0.27% |
| Aster DM Quality Care LimitedNSEI: ASTERDM | $6.29B | Rs699.85 | -1.28% |
| Fortis Healthcare LimitedNSEI: FORTIS | $6.13B | Rs786.25 | +0.16% |
| Sunway Healthcare Holdings BerhadKLSE: SUNMED | $6.00B | RM2.13 | +3.40% |
| RadNet, Inc.NasdaqGM: RDNT | $5.58B | $71.21 | +0.42% |
| Galenica AGSWX: GALE | $5.11B | CHF84.70 | -0.59% |
| LifeStance Health Group, Inc.NasdaqGS: LFST | $4.75B | $12.49 | +0.56% |
| Concentra Group Holdings Parent, Inc.NYSE: CON | $4.74B | $37.72 | +1.41% |
Figures last refreshed Oct 11, 2026.